Aimisen
Latest round
- Series C
Last raised
- Apr 2022
Total raised
- $31M
Investors
- 8
About Aimisen
Established in 2015 and based in Wuhan, China, Aimisen operates as a tumor early screening detection technology developer. The company was identified by "the national high technology enterprise 2020". Mr. Lianglu Zhang is the founder of the company. The company provides tumor detection technology for patients with colorectal cancer and cervical cancer. The business of the company includes IVD R & D, manufacturing, marketing, and medical testing. The company focuses on non-invasive screening and early detection products development and testing services for high incident malignant tumors. The company's product includes IColocomf® and ICON®series. The company adopts epigenetics, nanomaterials, bioinformatics, clinical big data and artificial intelligence.
Who invested in Aimisen
8 investors across 3 rounds
See all investors in Aimisen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aimisen
Who invested in Aimisen?
Aimisen has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aimisen raised?
Aimisen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Aimisen last raise money?
Aimisen's most recent round on record is a Series C, in Apr 2022.
What does Aimisen do?
Established in 2015 and based in Wuhan, China, Aimisen operates as a tumor early screening detection technology developer.
Where is Aimisen headquartered?
Aimisen is headquartered in Wuhan, China.
Which VCs invest in companies like Aimisen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Aimisen's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like Aimisen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.